Back to UBS Group AG UBS Group AG

ATHEATHE
Showing 5 of 9 quarters

Position history for UBS Group AGUBS Group AG's holdings in ALTERITY THERAPEUTICS LTD SPONSORED ADS

UBS Group AG holds 5 shares of ATHE (ALTERITY THERAPEUTICS LTD SPONSORED ADS), worth $27 as of 2026-Q2. This is a new position.

Current Value

$27

Current Shares

5

Total Value Change

-$16,616

Total Shares Change

-12,680

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
5
-
$270.0%$5.37
17
2025-Q2
Exited
0
-100.0%
$00.0%$3.93
0
2025-Q1
Increased
13,004
+3286.5%
$44,8640.0%$3.44
22
2024-Q4
Decreased
384
-97.0%
$1,2710.0%$3.50
0
2024-Q3
Increased
12,685
+6342x
$16,6430.0%$1.33
20

Other major holders of ATHE: Point72 Asset Management, L.P., MORGAN STANLEY, GREENLEAF TRUST, HB Wealth Management, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used